SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 123 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,437,012 | -30.2% | 98,969 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $2,057,377 | +107110.9% | 98,298 | +8.2% | 0.00% | 0.0% |
| Q1 2023 | $1,919 | -6.4% | 90,854 | +12.8% | 0.00% | -33.3% |
| Q4 2022 | $2,050 | -99.9% | 80,568 | +2.3% | 0.00% | 0.0% |
| Q3 2022 | $1,893,000 | +38.1% | 78,788 | +10.6% | 0.00% | +50.0% |
| Q2 2022 | $1,371,000 | +35.5% | 71,266 | +22.4% | 0.00% | +100.0% |
| Q1 2022 | $1,012,000 | -18.5% | 58,239 | +2.7% | 0.00% | -50.0% |
| Q4 2021 | $1,242,000 | +13.0% | 56,723 | -1.3% | 0.00% | +100.0% |
| Q3 2021 | $1,099,000 | +15.6% | 57,499 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $951,000 | +33.9% | 55,399 | +74.4% | 0.00% | 0.0% |
| Q1 2021 | $710,000 | -2.3% | 31,768 | -2.8% | 0.00% | 0.0% |
| Q4 2020 | $727,000 | +60.1% | 32,693 | +6.4% | 0.00% | 0.0% |
| Q3 2020 | $454,000 | -9.2% | 30,726 | -8.9% | 0.00% | 0.0% |
| Q2 2020 | $500,000 | +93.8% | 33,744 | +43.8% | 0.00% | 0.0% |
| Q1 2020 | $258,000 | +27.7% | 23,474 | +1.8% | 0.00% | – |
| Q4 2019 | $202,000 | +18.1% | 23,054 | +0.9% | 0.00% | – |
| Q3 2019 | $171,000 | -20.1% | 22,851 | -0.6% | 0.00% | – |
| Q2 2019 | $214,000 | +111.9% | 22,991 | +19.3% | 0.00% | – |
| Q1 2019 | $101,000 | +17.4% | 19,265 | -0.7% | 0.00% | – |
| Q4 2018 | $86,000 | -24.6% | 19,410 | +38.1% | 0.00% | – |
| Q3 2018 | $114,000 | +10.7% | 14,060 | -4.3% | 0.00% | – |
| Q2 2018 | $103,000 | – | 14,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |